{"disease":{"id":"emphysema","name":"emphysema"},"drugs":{"marketed":[{"drug_id":"vilanterol","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Breo Ellipta","generic_name":"VILANTEROL","company_name":"Glaxo Grp Ltd","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":60,"revenue":"3100","mechanism":"Breo Ellipta works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"fluticasone-furoate","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnuity Ellipta","generic_name":"FLUTICASONE FUROATE","company_name":"Haleon Us Holdings","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":62,"revenue":"3100","mechanism":""},{"drug_id":"umeclidinium","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Incruse Ellipta","generic_name":"UMECLIDINIUM","company_name":"Glaxo Grp England","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"Anticholinergic","quality_score":70,"revenue":"3100","mechanism":"Umeclidinium works by blocking the M4 muscarinic acetylcholine receptor to relax airway smooth muscle and improve breathing."},{"drug_id":"tiotropium-bromide","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spiriva","generic_name":"TIOTROPIUM BROMIDE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M3","drug_class":"Anticholinergic","quality_score":10,"revenue":"2500","mechanism":"Spiriva works by blocking the action of a chemical called acetylcholine, which causes airway muscles to contract and narrow the airways."},{"drug_id":"fluticasone-propionate","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cutivate","generic_name":"FLUTICASONE PROPIONATE","company_name":"Teva Pharm","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":64,"revenue":"69.0","mechanism":""},{"drug_id":"ethylnorepinephrine","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Butanefrine","generic_name":"ethylnorepinephrine","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Butanefrine works by stimulating the body's natural responses to constrict blood vessels and increase airway resistance."},{"drug_id":"flixotide","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Flixotide","company_name":"Mundipharma Research Limited","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"fluticason","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluticason","company_name":"Creighton University","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"theophyllin","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Theophyllin","company_name":"University of Bergen","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"epinephrine","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epipen","generic_name":"epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation."},{"drug_id":"norepinephrine","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norepinephrine Bitartrate In 5% Dextrose","generic_name":"NOREPINEPHRINE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"alpha-adrenergic receptors, beta-adrenergic receptors","drug_class":"Catecholamine","quality_score":80,"revenue":null,"mechanism":"Norepinephrine constricts blood vessels and stimulates the heart."},{"drug_id":"ipratropium","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atrovent","generic_name":"IPRATROPIUM","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Anticholinergic","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"lidocaine-hydrochloride-and-epinephrine","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"Epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels."},{"drug_id":"diprophylline","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diphyllin","generic_name":"diprophylline","company_name":"","drug_phase":"marketed","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4B","drug_class":"diprophylline","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"orciprenaline","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Metaproterenol","generic_name":"orciprenaline","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"terbutaline","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"bitolterol","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tornalate","generic_name":"BITOLTEROL","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"bitolterol","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"umec","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"UMEC","company_name":"Glaxo Grp England","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":"UmeC is a small molecule drug that works by interacting with a specific target in the body."},{"drug_id":"incruse","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Incruse","company_name":"Fundacio Privada Mon Clinic Barcelona","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"serevent","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Serevent","company_name":"Fundacio Privada Mon Clinic Barcelona","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"epinephrin","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Epinephrin","company_name":"United States Naval Medical Center, San Diego","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"brovana","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Brovana","company_name":"Wake Forest University Health Sciences","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-3 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"aminophyllin","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aminophyllin","company_name":"University of Padova","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"noradrenaline","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Noradrenaline","company_name":"Tanta University","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"formoterol","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foradil","generic_name":"FORMOTEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":56,"revenue":null,"mechanism":"Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"arformoterol","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brovana","generic_name":"ARFORMOTEROL","company_name":"Lupin","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":58,"revenue":null,"mechanism":"Brovana works by activating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"fluticasone","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flonase","generic_name":"fluticasone propionate","company_name":"GSK (GlaxoSmithKline)","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Inhaled/intranasal corticosteroid","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"indacaterol","indication_name":"Prevention of Bronchospasms with Emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arcapta Neohaler","generic_name":"INDACATEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":38,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":28,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06512142","title":"Using Artificial Intelligence for the Detection of Respiratory Diseases Associated With Pollution","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"University of Medicine and Pharmacy \"Victor Babes\" Timisoara","has_results":false},{"nct_id":"NCT06528418","title":"Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"ChromX Health","has_results":false},{"nct_id":"NCT01953523","title":"Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions","phase":"NA","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Elliot Lander","has_results":false},{"nct_id":"NCT04930289","title":"Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Paragonix Technologies","has_results":false},{"nct_id":"NCT06690385","title":"DEPRECAP: Lung Cancer Screening Programme by LDCT for Patients With COPD or Emphysema.","phase":"","overall_status":"RECRUITING","enrollment_count":1998,"lead_sponsor_name":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","has_results":false},{"nct_id":"NCT06533371","title":"Clinical-ultrasonographic Assessment of Pulmonary Emphysema","phase":"NA","overall_status":"RECRUITING","enrollment_count":1628,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03049202","title":"BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT05963945","title":"Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":956,"lead_sponsor_name":"Carebot s.r.o.","has_results":false},{"nct_id":"NCT05330637","title":"Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT02719184","title":"Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)","phase":"","overall_status":"COMPLETED","enrollment_count":463,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT03657121","title":"Mortality and Symptom Burden Post Hospitalisation With COPD","phase":"","overall_status":"COMPLETED","enrollment_count":447,"lead_sponsor_name":"Northumbria Healthcare NHS Foundation Trust","has_results":false},{"nct_id":"NCT04200079","title":"Kingston Chronic Obstructive Pulmonary Disease (COPD) Multidimensional Long Term Follow up Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Dr. Juan Pablo de Torres Tajes","has_results":false},{"nct_id":"NCT03480386","title":"Home Pulmonary Rehabilitation for COPD","phase":"NA","overall_status":"COMPLETED","enrollment_count":375,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT00823927","title":"Alveolar Macrophage Proteomics in HIV-associated Emphysema","phase":"","overall_status":"COMPLETED","enrollment_count":365,"lead_sponsor_name":"Philip Diaz","has_results":false},{"nct_id":"NCT02630316","title":"Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":326,"lead_sponsor_name":"United Therapeutics","has_results":true},{"nct_id":"NCT02713347","title":"Advancing Symptom Alleviation With Palliative Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT03318406","title":"Post-Market BTVA Registry","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Uptake Medical Technology, Inc.","has_results":false},{"nct_id":"NCT04435327","title":"Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT07326592","title":"Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD)","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":270,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT02439528","title":"Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06891755","title":"Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Apreo Health, Inc.","has_results":false},{"nct_id":"NCT02633293","title":"An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":243,"lead_sponsor_name":"United Therapeutics","has_results":true},{"nct_id":"NCT05717192","title":"BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation","phase":"NA","overall_status":"RECRUITING","enrollment_count":224,"lead_sponsor_name":"IHF GmbH - Institut für Herzinfarktforschung","has_results":false},{"nct_id":"NCT02696564","title":"Losartan Effects on Emphysema Progression","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"JHSPH Center for Clinical Trials","has_results":true},{"nct_id":"NCT04742114","title":"Effect of EPAP Device on Emphysema and Lung Bullae","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT06035120","title":"An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT05897424","title":"Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":185,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06361121","title":"Mid-point Transverse Process to Pleura Block Versus Thoracic Paravertebral Block in Posterolateral Thoracotomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Fayoum University Hospital","has_results":false},{"nct_id":"NCT03382106","title":"Smoking Cessation and Functional CT Assessment","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"Eric A. Hoffman","has_results":false},{"nct_id":"NCT04517916","title":"Zephyr Etude Post-Inscription (French Registry)","phase":"","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT02099799","title":"The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD","phase":"NA","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT04214587","title":"Biological Investigation of Explanted Endobronchial Lung Valves Study","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT04186546","title":"Zephyr Valve Registry (ZEVR)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT06332885","title":"Zephyr Valve Japan Post-Marketing Surveillance","phase":"","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT02879773","title":"Computed Tomography Assessment of Regional Ventilation (CURVE)","phase":"","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Heart of England NHS Trust","has_results":false},{"nct_id":"NCT03360396","title":"Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Boston Scientific Corporation","has_results":true},{"nct_id":"NCT07091838","title":"Lung Diffusing Capacities Normality Thresholds in Pulmonary Fibrosis and Emphysema","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy","has_results":false},{"nct_id":"NCT02056158","title":"HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT04932811","title":"The Lung Microbiome and Endobronchial Valve Treatment","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT02006576","title":"Prostaglandin Inhibition for Emphysema","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"University of Nebraska","has_results":true},{"nct_id":"NCT04559464","title":"Fissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status (CONVERT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT06000696","title":"Healthy At Home Pilot","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of Massachusetts, Worcester","has_results":false},{"nct_id":"NCT06152107","title":"A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false},{"nct_id":"NCT05856331","title":"Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT03636347","title":"A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Mereo BioPharma","has_results":false},{"nct_id":"NCT02022683","title":"To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr Valves","phase":"NA","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT03474471","title":"A Trial on the Effects of Bronchoscopic Lung Volume Reduction in Severe Emphysema.","phase":"NA","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT06826560","title":"Evaluation of Immunological, Microbiological and Metabolomic Profiles in COPD","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT07059637","title":"Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT03010592","title":"Studying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPD","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Royal Brompton & Harefield NHS Foundation Trust","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}